HIV: Helping Save Lives Through Early Diagnosis

Globally, HIV/AIDS claims more than two million lives each year. Further, the widespread co-infection of HIV with HBV and syphilis alters the clinical presentation with fatal consequences. Timely effective monitoring of people with HIV is crucial both in preventing those infected from developing AIDS and in limiting onward transmissions. Currently however, HIV diagnostic tools are limited to single marker detections, laboratorybased, require the input of skilled clinical personnel and are not suitable for transportation to resource limited regions – regions where infection rates are often at their highest. There is a driving need to develop new pointof-care (POC) technologies for early diagnosis and smart patient monitoring. Directly relevant to this objective, we are developing an affordable multi-functional, real-time handheld device, similar to glucose sensor, which is capable of detecting viral multiple markers from small sample volumes (e.g. a drop of blood). This approach enhances the specificity and the accuracy of early diagnosis and with the precise administration of antiretroviral drugs, HIV can be managed sustainably. Our POC prototype is based on Multi-marker Cantilever Nanosensors platform that integrates sample sorting (nanopillars) and surface capture chemistries. This technology offers many opportunities for direct detection of proteins such as antigens and antibodies against infectious organisms and potentially for the direct detection of organisms themselves without the need for labelling. Nanopillars acts as microfluidic sieve to separate and concentrate different markers of infection from clinical samples which are present in low copies. The antigens are detected and quantified by flowing across an array of cantilever nanosensors functionalised with carefully selected high affinity capture molecules raised against different (sub) types of HIV virions. Subsequently, the specific biomolecular binding event is translated into a nanomechanical signal analysed by the interference pattern created when they are illuminated by a laser. Here we find the sensor geometry and receptor chemistry are key to the limit of HIV multiple marker detection particularly in the regimens that allow for early diagnosis. We show that the cantilever arrays have the potential for highthroughput multi-target screening and are amenable for large scale production of compact, portable POC device to be used anywhere in the world.

[1]  Christopher M Thomas,et al.  A Natural Plasmid Uniquely Encodes Two Biosynthetic Pathways Creating a Potent Anti-MRSA Antibiotic , 2011, PloS one.

[2]  Cidália Pina-Vaz,et al.  Ibuprofen reverts antifungal resistance on Candida albicans showing overexpression of CDR genes. , 2009, FEMS yeast research.

[3]  David Tweats,et al.  Fexinidazole – A New Oral Nitroimidazole Drug Candidate Entering Clinical Development for the Treatment of Sleeping Sickness , 2010, PLoS neglected tropical diseases.

[4]  N. Pujol,et al.  Antifungal innate immunity in C. elegans: PKCdelta links G protein signaling and a conserved p38 MAPK cascade. , 2009, Cell host & microbe.

[5]  Solomon Nwaka,et al.  Innovative lead discovery strategies for tropical diseases , 2006, Nature Reviews Drug Discovery.

[6]  Alexis Criscuolo,et al.  Bacteriophages can treat and prevent Pseudomonas aeruginosa lung infections. , 2010, The Journal of infectious diseases.

[7]  W. Couet,et al.  Pharmacokinetics of Colistin and Colistimethate Sodium After a Single 80‐mg Intravenous Dose of CMS in Young Healthy Volunteers , 2011, Clinical pharmacology and therapeutics.

[8]  Daisuke Fukuda,et al.  Engineered thiomarinol antibiotics active against MRSA are generated by mutagenesis and mutasynthesis of Pseudoalteromonas SANK73390. , 2011, Angewandte Chemie.

[9]  A. Armaganidis,et al.  Population Pharmacokinetic Analysis of Colistin Methanesulfonate and Colistin after Intravenous Administration in Critically Ill Patients with Infections Caused by Gram-Negative Bacteria , 2009, Antimicrobial Agents and Chemotherapy.

[10]  Christian Scheurer,et al.  Synthetic ozonide drug candidate OZ439 offers new hope for a single-dose cure of uncomplicated malaria , 2011, Proceedings of the National Academy of Sciences.

[11]  Cidália Pina-Vaz,et al.  Potent synergic effect between ibuprofen and azoles on Candida resulting from blockade of efflux pumps as determined by FUN-1 staining and flow cytometry. , 2005, The Journal of antimicrobial chemotherapy.

[12]  L. Touqui,et al.  Pulmonary Bacteriophage Therapy on Pseudomonas aeruginosa Cystic Fibrosis Strains: First Steps Towards Treatment and Prevention , 2011, PloS one.

[13]  D. Levine,et al.  Vancomycin therapeutic guidelines: a summary of consensus recommendations from the infectious diseases Society of America, the American Society of Health-System Pharmacists, and the Society of Infectious Diseases Pharmacists. , 2009, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[14]  O. Zugasti,et al.  Neuroimmune regulation of antimicrobial peptide expression by a noncanonical TGF-β signaling pathway in Caenorhabditis elegans epidermis , 2009, Nature Immunology.

[15]  A Forrest,et al.  Population Pharmacokinetics of Colistin Methanesulfonate and Formed Colistin in Critically Ill Patients from a Multicenter Study Provide Dosing Suggestions for Various Categories of Patients , 2011, Antimicrobial Agents and Chemotherapy.

[16]  Bruce Russell,et al.  Spiroindolones, a Potent Compound Class for the Treatment of Malaria , 2010, Science.

[17]  Stephen Neidle,et al.  Bioactive pyridine-N-oxide disulfides from Allium stipitatum. , 2009, Journal of natural products.

[18]  Simon Gibbons,et al.  The Phenolic Diterpene Totarol Inhibits Multidrug Efflux Pump Activity in Staphylococcus aureus , 2007, Antimicrobial Agents and Chemotherapy.

[19]  Adam R Renslo,et al.  Drug discovery and development for neglected parasitic diseases , 2006, Nature chemical biology.

[20]  Michael P Barrett,et al.  Development of novel drugs for human African trypanosomiasis. , 2011, Future microbiology.

[21]  Katja Dierking,et al.  Unusual regulation of a STAT protein by an SLC6 family transporter in C. elegans epidermal innate immunity. , 2011, Cell host & microbe.